Cormorant Asset Management, LP Y M Abs Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

$1.27 Billion
Q4 2024

A detailed history of Cormorant Asset Management, LP transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 425,000 shares of YMAB stock, worth $2.43 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

425,000

Previous 1,450,000 70.69%

Holding current value

$2.43 Million

Previous $19 Million 82.52%

% of portfolio

0.26%

Previous 1.33%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$7.76 - $15.69 $7.95 Million - $16.1 Million	-1,025,000 Reduced 70.69%	425,000 $3.33 Million
Q2 2024 Aug 14, 2024	BUY	$11.6 - $17.25 $16.8 Million - $25 Million	1,450,000 New	1,450,000 $17.5 Million
Q1 2022 May 16, 2022	SELL	$6.55 - $17.42 $982,500 - $2.61 Million	-150,000 Reduced 50.0%	150,000 $1.78 Million
Q4 2021 Feb 14, 2022	SELL	$15.51 - $29.31 $3.1 Million - $5.86 Million	-200,000 Reduced 40.0%	300,000 $4.86 Million
Q3 2021 Nov 15, 2021	SELL	$27.47 - $37.31 $8.24 Million - $11.2 Million	-300,000 Reduced 37.5%	500,000 $14.3 Million
Q2 2021 Aug 16, 2021	SELL	$25.45 - $37.64 $10.9 Million - $16.2 Million	-430,000 Reduced 34.96%	800,000 $27 Million
Q1 2021 May 17, 2021	SELL	$29.16 - $51.96 $12.6 Million - $22.4 Million	-431,647 Reduced 25.98%	1,230,000 $37.2 Million
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $9.99 Million - $14.3 Million	263,947 Added 18.88%	1,661,647 $82.3 Million
Q3 2020 Nov 16, 2020	SELL	$35.13 - $43.62 $6.22 Million - $7.72 Million	-176,983 Reduced 11.24%	1,397,700 $53.7 Million
Q2 2020 Aug 14, 2020	SELL	$23.66 - $49.53 $3.73 Million - $7.8 Million	-157,517 Reduced 9.09%	1,574,683 $68 Million
Q1 2020 May 15, 2020	BUY	$14.39 - $35.8 $1.87 Million - $4.65 Million	129,824 Added 8.1%	1,732,200 $45.2 Million
Q4 2019 Feb 14, 2020	BUY	$23.81 - $33.78 $17.1 Million - $24.3 Million	718,576 Added 81.31%	1,602,376 $50.1 Million
Q3 2019 Nov 14, 2019	SELL	$21.57 - $31.37 $2.51 Million - $3.65 Million	-116,200 Reduced 11.62%	883,800 $23 Million
Q2 2019 Aug 14, 2019	BUY	$19.51 - $28.31 $5.55 Million - $8.05 Million	284,518 Added 39.77%	1,000,000 $22.9 Million
Q1 2019 May 15, 2019	BUY	$18.21 - $26.21 $9.48 Million - $13.6 Million	520,714 Added 267.35%	715,482 $18.8 Million
Q4 2018 Feb 14, 2019	SELL	$15.41 - $28.92 $80,625 - $151,309	-5,232 Reduced 2.62%	194,768 $3.96 Million
Q3 2018 Nov 14, 2018	BUY	$24.0 - $26.97 $4.8 Million - $5.39 Million	200,000 New	200,000 $5.31 Million

Others Institutions Holding YMAB

# of Institutions

113

Shares Held

26.9M

Call Options Held

5.6K

Put Options Held

900

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $250M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account

Cormorant Asset Management, LP Y M Abs Therapeutics, Inc. Transaction History